Xiang T - Search Results

1

Cancer-Associated Fibroblast-Mediated Cellular Crosstalk Supports Hepatocellular Carcinoma Progression.

Song M, He J, Pan QZ, Yang J, Zhao J, Zhang YJ, Huang Y, Tang Y, Wang Q, He J, Gu J, Li Y, Chen S, Zeng J, Zhou ZQ, Yang C, Han Y, Chen H, Xiang T, Weng DS, Xia JC. Song M, et al. Among authors: xiang t. Hepatology. 2021 May;73(5):1717-1735. doi: 10.1002/hep.31792. Hepatology. 2021. PMID: 33682185

2

Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma.

Zhu Q, Zhong AL, Hu H, Zhao JJ, Weng DS, Tang Y, Pan QZ, Zhou ZQ, Song MJ, Yang JY, He JY, Liu Y, Li M, Hu WM, Yang CP, Xiang T, Chen MY, Ma G, Guo L, Xia JC. Zhu Q, et al. Among authors: xiang t. J Hematol Oncol. 2020 Jan 3;13(1):2. doi: 10.1186/s13045-019-0840-4. J Hematol Oncol. 2020. PMID: 31900208 Free PMC article.

3

Inhibition of DTYMK significantly restrains the growth of HCC and increases sensitivity to oxaliplatin.

Sun F, Liu Y, Gong T, Pan Q, Xiang T, Zhao J, Tang Y, Chen H, Han Y, Song M, Huang Y, Li H, Chen Y, Yang C, Yang J, Wang Q, Li Y, He J, Weng D, Peng R, Xia J. Sun F, et al. Among authors: xiang t. Cell Death Dis. 2021 Nov 18;12(12):1093. doi: 10.1038/s41419-021-04375-3. Cell Death Dis. 2021. PMID: 34795209 Free PMC article.

4

EBV Infection in Epithelial Malignancies Induces Resistance to Antitumor Natural Killer Cells via F3-Mediated Platelet Aggregation.

Duan X, Chen H, Zhou X, Liu P, Zhang X, Zhu Q, Zhong L, Zhang W, Zhang S, Zhang X, Chen Y, Zhou Y, Yang C, Feng Q, Zeng YX, Xu M, Xiang T. Duan X, et al. Among authors: xiang t. Cancer Res. 2022 Mar 15;82(6):1070-1083. doi: 10.1158/0008-5472.CAN-21-2292. Cancer Res. 2022. PMID: 35064016

5

CircITGB6 promotes ovarian cancer cisplatin resistance by resetting tumor-associated macrophage polarization toward the M2 phenotype.

Li H, Luo F, Jiang X, Zhang W, Xiang T, Pan Q, Cai L, Zhao J, Weng D, Li Y, Dai Y, Sun F, Yang C, Huang Y, Yang J, Tang Y, Han Y, He M, Zhang Y, Song L, Xia JC. Li H, et al. Among authors: xiang t. J Immunother Cancer. 2022 Mar;10(3):e004029. doi: 10.1136/jitc-2021-004029. J Immunother Cancer. 2022. PMID: 35277458 Free PMC article.

6

CMTM6 inhibits tumor growth and reverses chemoresistance by preventing ubiquitination of p21 in hepatocellular carcinoma.

Huang Y, Zhu Y, Yang J, Pan Q, Zhao J, Song M, Yang C, Han Y, Tang Y, Wang Q, He J, Li Y, He J, Chen H, Weng D, Xiang T, Xia JC. Huang Y, et al. Among authors: xiang t. Cell Death Dis. 2022 Mar 19;13(3):251. doi: 10.1038/s41419-022-04676-1. Cell Death Dis. 2022. PMID: 35304440 Free PMC article.

7

SPC25 promotes proliferation and stemness of hepatocellular carcinoma cells via the DNA-PK/AKT/Notch1 signaling pathway.

Yang J, Huang Y, Song M, Pan Q, Zhao J, He J, Ouyang D, Yang C, Han Y, Tang Y, Wang Q, He J, Li Y, Chen H, Weng D, Xiang T, Xia J. Yang J, et al. Among authors: xiang t. Int J Biol Sci. 2022 Aug 15;18(14):5241-5259. doi: 10.7150/ijbs.71694. eCollection 2022. Int J Biol Sci. 2022. PMID: 36147467 Free PMC article.

8

OTUD4-mediated GSDME deubiquitination enhances radiosensitivity in nasopharyngeal carcinoma by inducing pyroptosis.

Di M, Miao J, Pan Q, Wu Z, Chen B, Wang M, Zhao J, Huang H, Bai J, Wang Q, Tang Y, Li Y, He J, Xiang T, Weng D, Wang L, Xia J, Zhao C. Di M, et al. Among authors: xiang t. J Exp Clin Cancer Res. 2022 Nov 21;41(1):328. doi: 10.1186/s13046-022-02533-9. J Exp Clin Cancer Res. 2022. PMID: 36411454 Free PMC article.

9

Adjuvant alternative cytokine-induced killer cell combined with natural killer cell immunotherapy improves the prognosis of post-mastectomy breast cancer.

Yang X, Weng D, Pan Q, Xiang T, Yang C, Wu Z, Li M, Xie S, Tang Y, Xia J, Zhao J. Yang X, et al. Among authors: xiang t. Front Immunol. 2022 Nov 10;13:974487. doi: 10.3389/fimmu.2022.974487. eCollection 2022. Front Immunol. 2022. PMID: 36439119 Free PMC article.

10

EBV-Upregulated B7-H3 Inhibits NK cell-Mediated Antitumor Function and Contributes to Nasopharyngeal Carcinoma Progression.

Chen H, Duan X, Deng X, Huang Y, Zhou X, Zhang S, Zhang X, Liu P, Yang C, Liu G, Ren Q, Xiong Y, Zhu B, Zhang J, Xiang T. Chen H, et al. Among authors: xiang t. Cancer Immunol Res. 2023 Jun 2;11(6):830-846. doi: 10.1158/2326-6066.CIR-22-0374. Cancer Immunol Res. 2023. PMID: 36996321

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

986 results

Search Page